Podcasts about Pulmonary rehabilitation

In this episode of the AARC Perspectives Podcast, we are joined by AARCchampion Steve Wehrman, RRT, RPFT, FAARC, a 48-year member of AARC and virtual pulmonary rehab therapist who discusses professionalism, the importance of RTs, and especially how AARC has shaped his life and journey.  Additional Resources:Virtual Pulmonary Rehabilitation: Opportunities for RTsAbout our guest- Steve WehrmanSend us a textSupport the show

Guidelines from the American Thoracic Society report on the value of pulmonary rehabilitation for people with COPD, interstitial lung disease, or pulmonary hypertension. JAMA Clinical Guidelines Synopsis author Michaela R. Anderson, University of Pennsylvania, discusses these guidelines and more with JAMA Associate Editor David Simel, MD, MHS. Related Content: Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease Proper Use of Inhalant Medications for Chronic Respiratory Diseases

Welcome to Hally Healthcast, the wellness podcast from Hally® health – your partner in helping you live your healthiest life.Every episode on our podcast addresses a new topic important to your health and well-being, bringing in doctors, specialists and other health experts who offer advice and answer your most pressing questions.Today's episode is all about chronic obstructive pulmonary disease, or COPD, and pulmonary rehabilitation. November is COPD Awareness Month, so it's the perfect time to learn more about COPD and how we can improve the lives of those affected by this disease – including treatments such as pulmonary rehabilitation.Here with us is Sarah Moore. She's a respiratory care practitioner coordinator at Carle FoundationHospital's Pulmonary Rehabilitation department in Urbana. Welcome, Ms. Moore, and thank you somuch for being with us today and sharing your knowledge

How can you improve symptoms of breathlessness in a patient with chronic respiratory disease? What's the link between diabetes and frailty? How long is a child with measles contagious for? In this episode of the Clinical Update podcast, MIMS Learning editors discuss pulmonary rehabilitation – who it is suitable for and what it entails. Our guest for this episode, MIMS Learning's diabetes clinical adviser Dr Tom Crabtree, discusses the impact of frailty on the management of diabetes. Finally, we offer three key learning points for you on measles.You can access the website version of this podcast on MIMS Learning [link] to make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.Useful linksPulmonary rehabilitationPulmonary rehabilitation for people with breathlessnessAdjunct therapies for chronic respiratory conditions learning planDiabetes and frailtyDiabetes and older people webinarPodcast: Monkeypox and diabetes technologyDiabetes research briefing March 2023MeaslesEspresso CPD: measlesRegister to access contentRegister for a free MIMS Learning healthcare professional account Hosted on Acast. See acast.com/privacy for more information.

Despite well-established evidence of pulmonary rehabilitation (PR)effectiveness, inadequate US reimbursement has resulted in challenges that negatively impact PR financial stability, equity and access. The road to equitable payment and access to PR is a long and complex journey. All major pulmonary societies are working together to improve equity of PR reimbursement. ATS recently published a PR clinical practice guideline to update the evidence base of PR and further substantiate and define PR's highly effective impact. As the evidence base of effectiveness improves, we all play a role in understanding and working toward improving patient program access, awareness, and adequate payment.

In this episode, certified health coach Linda Hohbein leads a discussion focusing on pulmonary rehab, giving insight into the program and the treatment options.

In this podcast, Ellen Duckers and John Hurst discuss health inequities in patients with pulmonary disease and how this intersects with pulmonary rehabilitation. Topics include program development and growth, and areas of future research.

In this episode, I revisit the topic of COVID19 and pulmonary rehab, with a focus on rehab for patients with Long COVID. I mention a number of resources and papers, listed below:   1.  Perumal R, Shunmugam L, Naidoo K et al. Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol 2023; 14: 1117464. Accessed July 4, 2023 at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157068/   2.  Journal of Health Economics and Outcomes Research Blog. Economic Effects of Long COVID Even Larger Than We Thought. Published December 13, 2022. Accessed July 4, 2023 at https://jheor.org/post/1746-economic-effects-of-long-covid-even-larger-than-we-thought   3.  Barker-Davies RM, O'Sullivan O, Pumi Prathima Senaratne K, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020; 949-59. Accessed July 4, 2023 at https://bjsm.bmj.com/content/bjsports/54/16/949.full.pdf   4.  Cochrane Rehabilitation. REH-COVER – Rapid Living Systematic Reviews. Accessed July 4, 2023 at https://rehabilitation.cochrane.org/covid-19/reh-cover-rapid-living-systematic-reviews   5.  Canadian Physiotherapy Association. Rehabilitation for Clients with Post COVID-19 Condition (Long COVID). Guidance for Canadian Rehabilitation and Exercise Professionals. Accessed July 4, 2023 at https://physiotherapy.ca/app/uploads/2022/08/long_covid_en-final-rev2.pdf   6.  World Health Organization. Clinical Management of COVID19: living guideline. V6.0. Accessed July 4, 2023 at https://app.magicapp.org/#/guideline/j1WBYn/section/j7A12z I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section here on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

Well we missed celebrating our big 5-0 episode a few weeks back and so we will make up for that in the near future! In this episode I am talking about Collaborative Practice in Pulmonary Rehabilitation & how different individuals and disciplines work together to provide rehab programs. The definition of pulmonary rehab includes language about how it's a multidisciplinary intervention, but the reality of many programs is that so often it is just one or two people who are doing everything, but that doesn't mean collaboration doesn't happen or can't happen.  So let's lean in and explore the concepts of collaborative practice in this episode! I talk about this paper in this episode: PR in Canada- A report from CTS And this paper from CIHC  here. I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section here on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

Register now for ATS 2023 in Washington, D.C.Get ready for a series of dynamic scientific programming with presentations covering the basic sciences, research breakthroughs and clinical treatment!In this podcast, Astrid Blondeel and Mark Orme discuss the technical aspects of Physical Activity measurement in Pulmonary Rehabilitation. This includes defining physical activity, why measuring this is important and the merits/ pitfalls of subjective and objective measures.

On this episode I talk about a new paper we recently published on the safety and efficacy of pulmonary rehabilitation for individuals hospitalized with an acute exacerbation of COPD. The paper can be found here. I also mention the Cochrane Review by Milo Puhan. That paper can be found here. I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section here on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

What is Pulmonary Rehabilitation? What are the benefits? Crockett is joined by Lorri Snyder and Emily Pettit of Wellspan York to discuss these questions and more in this episode of the PULMONARY FIBROSIS podcast! Brought to you by the PAIPF Support Network – visit paIPFsupportnetwork.org! And by the Wescoe Foundation for Pulmonary Fibrosis! Find the Pulmponary Fibrosis podcast wherever you get your podcasts!See omnystudio.com/listener for privacy information.

Featured Guest: Karla R. Enderle- Registered Respiratory Specialist at U.S. Department of Veteran Affairs Highly ambitious and self-motivated healthcare professional with 16 years of experience in Respiratory Therapy & Cardiopulmonary Care. Skilled in Adult Critical Care, Emergency/Trauma, Adult Acute Care, Pulmonary Rehabilitation, Telehealth/VVC Care, & Outpatient Cardiopulmonary Diagnostics. Her interests include pulmonary disease management, process improvement, systems redesign, change management, healthcare innovation, quality improvement, patient education, and healthcare leadership. Passionate about improving the care being provided to our nation's Veterans, employee experience & engagement.

Hi everyone, and welcome to the LungFIT podcast. I am going to be taking a much needed break for the next while, so I hope you enjoy this past episode on who's missing from pumonary rehabilitation. I'll be back soon with new content, but until then, thank you again for your support. In this talk, I discuss concepts related to who is missing from pulmonary rehabilitation. I mention a study we did in Canada to characterize the pulmonary rehabilitation programs which were running in 2015. The link to that paper is here (https://cts-sct.ca/wp-content/uploads/2018/02/PR-in-Canada-Report_CRJ.pdf) I also mention a systematic review on several pulmonary rehabilitation survey studies, the link to that paper is here. https://www.tandfonline.com/doi/abs/10.3109/15412555.2014.922066 The Cochrane review I spoke of can be found here: https://www.cochrane.org/CD003793/AIRWAYS_pulmonary-rehabilitation-for-chronic-obstructive-pulmonary-disease and the associated editorial is found here: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.ED000107/full The link to Dr. Jenny Alison's and Mr. David Meharg's Breathe Easy podcast episode on the American Thoracic Society Pulmonary Rehabilitation Assembly's website can be found here: https://www.thoracic.org/about/ats-podcasts/pulmonary-rehabilitation-for-hard-to-reach-populations-focus-on-indigenous-people.php I also talk a bit about health inequality in pulmonary rehabilitation in a different American Thoracic Society Breathe Easy podcast, which can be found here: https://www.thoracic.org/about/ats-podcasts/health-inequality-in-pulmonary-rehabilitation.php If you want to read a bit more about intersectionality and health care, I found this paper published in the Lancet to be very helpful in explaining this complicated concept: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31431-4/fulltext I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

Fatigue Outcome Measures 

Hi everyone, and welcome to the LungFIT podcast. I am going to be taking a much needed break for the next while, so I hope you enjoy this past episode about some questions related to pulmonary rehabilitation and COVID-19. I'll be back soon with new content, but until then, thank you again for your support. On this episode, I talk about COVID-19 and pulmonary rehabilitation, including questions that health care professionals should ask themselves when they consider admitting patients who have had COVID-19 and ongoing symptoms. I mentioned some papers that I would recommend reading, that discuss some of these questions in more detail, as well as provide guidance to you as you consider caring for patients who have had COVID-19, in your pulmonary rehabilitation programs. Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.02197-2020). This paper can be found here.   American Thoracic Society Assembly on Pulmonary Rehabilitation. “Guidance for Re-opening Pulmonary Rehabilitation Programs.” This paper can be found here.   American Physical Therapy Association Webinars on “Physical Therapy Considerations of COVID-19 in the Post-Acute Setting” aired on April 18, 2020 and “COVID-19: Clinical Best Practices in Physical Therapy Management”, aired on March 28, 2020. 

Hi everyone, and welcome to the LungFIT podcast. I am going to be taking a much needed break for the next while, so I hope you enjoy this past episode about the history of pulmonary rehabilitation. I'll be back soon with new content, but until then, thank you again for your support. In this episode, I provide a brief overview of the history of pulmonary rehabilitation.   I mention several papers in this episode. Several of them are open-access: Celli BR, Goldstein RS. A historical perspective of pulmonary rehabilitation. In: Clini E, Holland AE, Pitta F, Troosters T, eds. Textbook of Pulmonary Rehabilitation. Springer, 2018. Denison C. Exercise and Food for Pulmonary Invalids. Available from Amazon: https://www.amazon.com/Exercise-Pulmonary-Invalids-Classic-Reprint/dp/B008C4AT8E. Petty TL, Nett LM, Finigan MM, Brink GA, Corsello PR. A comprehensive care program for chronic airway obstruction. Annals of Internal Medicine 1969; 70(6):1109-1120. https://pubmed.ncbi.nlm.nih.gov/5789505/ Barach AL. A Treatment Manual for Patients with Pulmonary Emphysema. New York, NY: Grune & Stratton, Inc.; 1969. Hodgkin JE, Balchum OJ, Kass I, Glaser EM, Miller WF, Haas A, Shaw DB, Kimbel P, Petty TL. Chronic obstructive airway diseases. Current concepts in diagnosis and comprehensive care. JAMA 1975; 232:1243–60. https://jamanetwork.com/journals/jama/article-abstract/336862 Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982; 284:1607–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1498516/ Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773–8. https://thorax.bmj.com/content/thoraxjnl/42/10/773.full.pdf Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992 ;145:1321–7. https://pubmed.ncbi.nlm.nih.gov/1595997/ Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47:1019–24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1021093/ Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet 1994; 344:1394–7. https://pubmed.ncbi.nlm.nih.gov/7968075/ Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS, Koeter GH. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J 1994; 7:269–73. https://pubmed.ncbi.nlm.nih.gov/8162979/. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122:823–32. https://pubmed.ncbi.nlm.nih.gov/7741366/. Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:442–7. https://pubmed.ncbi.nlm.nih.gov/8756820/ Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; Oct 18;(4):CD003793. https://pubmed.ncbi.nlm.nih.gov/17054186/ McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2:CD003793. https://pubmed.ncbi.nlm.nih.gov/25705944/   I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

Amanda is a Kinesiologist and Certified Clinical Exercise Physiologist. She is also the founder and CEO of iMaster Health. Her experience working in academia and healthcare allowed her to recognize a global gap in rehabilitative care. In turn she built a business focused on implementing technology-based solutions to reduce a major strain on the healthcare systems and improve patients' quality of life. iMaster health is an online pulmonary rehabilitation program that is available now! Amanda joins the fellas to talk about why applications like iMaster health are important and how they can serve to fill gaps in our healthcare system. Check out https://www.imasterhealth.com/ for more info! Join the post-episode conversation over on Discord! https://discord.gg/expeUDN

Amanda is a Kinesiologist and Certified Clinical Exercise Physiologist. She is also the founder and CEO of iMaster Health. Her experience working in academia and healthcare allowed her to recognize a global gap in rehabilitative care. In turn she built a business focused on implementing technology-based solutions to reduce a major strain on the healthcare systems and improve patients' quality of life. iMaster health is an online pulmonary rehabilitation program that is available now! Amanda joins the fellas to talk about why applications like iMaster health are important and how they can serve to fill gaps in our healthcare system. Check out https://www.imasterhealth.com/ for more info! Join the post-episode conversation over on Discord! https://discord.gg/expeUDN

Speech Pathology AustraliaAmerican Speech-Language-Hearing Association (ASHA)European Speech and Language Therapy AssociationGuestA/Prof Anne VertiganUniversity of Newcastle, and Treatable Traits Centre of Research Excellence, Australia HostDr Hayley LewthwaiteUniversity of Newcastle, and Treatable Traits Centre of Research Excellence, Australia 

Improving chronic lung diseases, like COPD, by adding Pulmonary Rehabilitation.

HostAlex Jenkins, PhDMcGill University, Canada ATS Evidence Synthesis Methodology Working Group MemberGuestArwel Jones, PhDMonash University, AustraliaTSANZ Evidence-Based Medicine & Practice Special Interest Group & ERS Clinical Practice Guideline Methodology Network Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training 

For episode 5 of the Clinical Audit and Improvement Podcast, Nicola Hurton from Leicestershire Partnership NHS Trust and James Osborne from University Hospitals Bristol and Weston NHS Foundation Trust discuss how they manage NICE guidance and statements of compliance.This episode's guests:Nicola Hurton is NICE Lead and Quality Improvement advisor at Leicestershire Partnership NHS Trust. She joined the NHS in 2004 to lend administrative expertise in a variety of roles from physiotherapy to long term conditions, eventually providing support first for the DESMOND diabetic education training programme and then the Pulmonary Rehabilitation programme.James Osborne is NICE Manager at University Hospitals Bristol and Weston NHS Foundation Trust. He joined the NHS in 1977 as a Biomedical Scientist. Since then, James has gained experience in developing guidelines, internal and external quality assurance, and the provision of clinical data for research and clinical audit support. Hosted on Acast. See acast.com/privacy for more information.

Access ATS 2022 On-Demand Highlights Starting May 25.GuestStephen Kirkby, MD  Dr. Kirkby is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children's Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. HostAndres Herrera-Camino, MD  Dr. Herrera-Camino is an Assistant Professor of Child Health at the University of Arizona College of Medicine-Phoenix and he is a faculty member in the divisions of Pediatric Pulmonary and Critical Care Medicine at Phoenix Children's Hospital in Phoenix, Arizona.  

x

In the seventh and final episode of season two, we are joined by our courageous group of guests made up of those living with various pulmonary fibrosis conditions, their care partners and specialized doctors. In this episode, we explore the benefits pulmonary rehabilitation can have on those living with the condition in helping them understand their new limits. While these adjustments can be frustrating, we'll hear how our guests have not only adapted their new exercise routines but also their mental outlook on fitness to remain positive and as healthy as possible.

On this episode, I talk about our new pulmonary rehabilitation course. It's called: “Creating an Evidence-Based Pulmonary Rehabilitation Program” and it's an online, self-paced course designed to provide you what you need to plan your pulmonary rehabilitation program. If you'd like to register for the course, here is the link.  The course will start March 7 and run until April 7, although the course site will stay open for a couple of months after that in case it takes you a bit longer to get through the material. I hope you'll consider registering for this course! So far we have registrants from North America and the Middle East! I'm really excited to meet everyone and create more community related to pulmonary rehabilitation.

Season 2 | Episode 6 | February 9, 2022Southwestern Vermont Health Care's (SVHC) Medical Matters Weekly with Dr. Trey Dobson is pleased to welcome Physical Therapist Caitlyn Boyd, DPT. She shared information about pulmonary rehabilitation and how it can help those with breathing difficulties.Boyd received both her bachelor's in Nutrition and Food Science and her doctorate of Physical Therapy from the University of Vermont. She has worked as a physical therapist at SVMC for the past 10 years. She specializes in vestibular rehab, which relates to the inner ear's role in balance and movement. She helped create the Pulmonary Rehab program in 2015 and serves as its coordinator. She is certified in pulmonary rehab by the American Association for Respiratory Care and the American Association of Cardiovascular and Pulmonary Rehabilitation.The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. The show is also available to view or download a podcast on www.svhealthcare.org/medicalmatters.Underwriter: Mack Molding

Tammie Fournier, Chair of the Allied Health Department at the New Brunswick Community College, comes on the show today to talk about the Healthy Seniors pilot project: Innovative and community Partnered Pulmonary Rehabilitation for Seniors in New Brunswick. We're all aging, and everyone's talking about it!   Key Takeaways [:40] Jenna welcomes today's guest, Tammie Fournier, and asks her to share the inspiration for the Healthy Seniors pilot project she is currently leading. [3:26] COPD stands for Chronic Obstructive Pulmonary Disease, Tammie talks about how prevalent this condition actually is and the vast array of issues that stem from this condition as well as the current methods of management for affected people. [6:47] Tammie touches on the goals of the program and how the environment is structured and how they hope it will improve outlooks for COPD patients. [8:28] The project is currently targeting around 40 seniors struggling with COPD so that the communal aspect of this group project can be adequately monitored and tested. Tammie touches on her hopes for the future of the program. [10:32] Tammie breaks down where exactly the five clinics will be located within New Brunswick and how COVID-19 has impacted their plans. [12:40] Tammie breaks down the measured outcomes of the project and shares some stories of participants. She also shares some of the methodologies used for measuring improvement and some unofficial preliminary results! [16:50] Blood oxygen levels non-invasively share a wealth of information on lung and heart function. [18:13] The 74 students that help in the project come from a variety of health fields ranging from respiratory therapy to pharmacy technology and nursing. [21:18] Tammie shares her hopes for the future of this project. [24:08] Jenna thanks Tammie for coming on the podcast. Until next time, subscribe, rate, and share! If you enjoyed today's episode, make sure to subscribe, rate us, and visit our website at agewell-nih-appta.ca/mileage-podcast for more information.   Mentioned in this episode The MileAGE Podcast New Brunswick Community College Innovative and Community-Partnered Pulmonary Rehabilitation for Seniors in New Brunswick   More about your hosts Jenna Roddick at APPTA Jenna Roddick on Twitter Jenna Roddick on LinkedIn

On this episode, I talk about 5 great apps for use in pulmonary rehab. These apps are available from the Apple App Store and the Google Play Store. This isn't a sponsored episode; these are just my opinions and impressions about the usefulness of these apps in pulmonary rehab. The apps, in order, are: Read by QxMD Twitter iWalkAssess Calculate by QxMD Zoom   QxMD has a website; it can be found here. The Twitter accounts I mention are @PR_Assembly, and my account which is @UBCPulmRehabRes. I also talk about AECOPD-Mob. The tool can be found here and the app can be found on Calculate by QxMD. iWalkAssess also has a webpage which has more detail about the app. It can be found here.

GuestDr Daniel Langer, KU LuevenHostDr Enya Daynes, University Hospitals of Leicester 

In this episode, we celebrate 20 years of transforming cardiovascular care, together. From physician-hospital integration, to major legislative reform, to a global pandemic, the MedAxiom community, alongside the American College of Cardiology (ACC), has always found a way to meet the challenge of the day, pushing the needle towards innovation. On MedAxiom HeartTalk, host Melanie Lawson sits down with a powerhouse panel, who have been there since the start: Ed Fry, MD, FACC, Cathie Biga, MSN, RN, FACC, and Jerry Blackwell, MD, MBA, FACC. They discuss how it all began, the impact of collaboration, and their thoughts on what the future holds.Guest Bios:Jerry Blackwell, MD, MBA, FACC, is President and CEO of MedAxiom. Blackwell graduated from Marshall University's Joan C. Edwards School of Medicine and completed residency/chief residency/fellowship at the Ohio State University and the University of Alabama - Birmingham. He earned his executive MBA from the University of Tennessee. He has more than 30 years of experience in cardiovascular medicine including academic cardiology, private practice and large integrated cardiovascular group leadership. Most recently, he served as executive vice president and chief clinical officer of the Ballad Health System.Blackwell has a passion for physician leadership, teaching, and care transformation - particularly team-based care and organizational performance improvement. He maintains a clinical practice with special interests in advanced imaging, including cardiovascular magnetic resonance imaging, cardiovascular CT angiography, and cardiac positron emission tomography.Blackwell has been involved with both MedAxiom and the American College of Cardiology for many years. He has served on the ACC's Board of Governors, the board of directors for the Cardiology Advocacy Alliance, and the ACC's Health Affairs Committee.Ed T.A. Fry, MD, FACC, is Chair of Ascension Health Cardiovascular Service Line and Vice President of the ACC. Fry attended medical school at Washington University School of Medicine in St. Louis and completed his residency in internal medicine at Barnes-Jewish Hospital. He completed a two-year cardiovascular research fellowship focused on pharmacokinetics/pharmacodynamics of native and genetically modified plasminogen activators. He also completed a general cardiology fellowship at Washington University, where he then served as assistant professor and medical director of the cardiac transplant program before completing an interventional cardiology fellowship at Ascension St. Vincent Hospital – Indianapolis.In 1991, he joined the cardiology practice at St. Vincent where he continues to be a busy interventional and general cardiologist and serves as chair of the Ascension National Cardiovascular Service Line. He helped launch Navion Healthcare Solutions, a subsidiary data quality management software company owned by Ascension, where he previously served as board chair.Fry is past president and governor of ACC's Indiana Chapter. Within the ACC, he has served on the Audit and Compliance Committee (Chair), Digital Strategy Steering Committee; Interventional Section Leadership Council; Surviving MI Initiative; Integrating the Health Enterprise Health Policy Work Group; Clinical Quality Committee; Prior Authorization Work Group; ACC Telemedicine Project; ACC COVID-19 Hub; Board of Governors Steering Committee; Innovations Development Work Group; ACC Premier Oversight Work Group (chair); Board of Trustees (BOT) Task Force on Clinician Well-Being; Health Systems Task Force; ACC/AHA Ethics and Professionalism Consensus Task Force, and ACC Nominating Committee. He has been a presenter, moderator and session chair at ACC Annual Scientific Session, ACC CV Summit, MedAxiom CV Transforum, Heart House Roundtables and is a member of HeartPAC, ACC's political action committee. He currently serves on ACC's BOT.Cathie Biga, MSN, RN, FACC, is President and CEO of Cardiovascular Management of Illinois, a cardiology physician practice management company. She works with more than 100 providers in the Chicago, IL, area and partners in their cardiovascular service lines at more than 14 acute care hospitals. She earned her Bachelor of Science degree in nursing from the Mayo/College of St. Teresa and Master of Science in nursing at Northern Illinois University School of Nursing.Biga has more than 40 years of experience as a registered nurse, service line director, hospital vice president and CEO. She has 20 years of experience in physician practice management.She has been active nationally in consulting in strategic planning, operational efficiencies, integrated financial and quality initiatives, and growth and development of the cardiovascular service lines. She is focused on facilitating the integration of strategic, financial and quality perspectives between cardiovascular service lines at practices and hospitals. In addition, she consults and lectures on numerous contemporary cardiovascular topics.Biga is a member of ACC's Board of Trustees, Chair of the MedAxiom Board of Managers, a member of the American Association of Cardiovascular and Pulmonary Rehabilitation and an ACC Fellow.

On this episode, I interview Dr. Clarice Tang from the University of Western Australia in Sydney, Australia about culturally- and linguistically-diverse populations and pulmonary rehabilitation. Dr. Tang's website is here – you can find links to her publications there. She mentions the BOLD study by Sonia Buist. That paper can be found here. We also had two previous episodes that touched on aspects of diversity in pulmonary rehabilitation. The are: “Who's Missing From Pulmonary Rehabilitation” and “A Review of 4 Important PR Papers from 2020-2021”.

Keeping healthy with COPD can be challenging. But for people like Jean, Jan, and John, COPD doesn't have to get in the way of life. It just means life looks a little different. Things like exercise, nutrition, and preventive care require more attention and planning, but these healthy habits (and good adherence to treatment regimens) can help people with lung disease continue to do the things they love— even in the middle of a global pandemic. Visit our website links and resources: HealthUnmuted.com List of Resources COPD360Social, social media support group: https://www.copdfoundation.org/COPD360social/Community/Get-Involved.aspx    My COPD Action Plan, from COPD Foundation: https://www.copdfoundation.org/Learn-More/Educational-Materials-Resources/Downloads.aspx#MyCOPDActionPlan  For more information about support groups for COPD:  Healthline's list of support groups: https://www.healthline.com/health/copd/support-groups-for-severe-copd  For more information on exercise:  Pocket Consultant Guide from the COPD Foundation: https://www.copdfoundation.org/Learn-More/Educational-Materials-Resources/Downloads.aspx#MyCOPDActionPlan  COPD Foundation information on pulmonary rehabilitation: https://www.copdfoundation.org/Learn-More/Pulmonary-Rehabilitation/What-is-Pulmonary-Rehabilitation.aspx  National Institutes of Health information on pulmonary rehab: https://www.nhlbi.nih.gov/health-topics/pulmonary-rehabilitation  For more information on nutrition:  Cleveland Clinic: https://my.clevelandclinic.org/health/articles/9451-nutritional-guidelines-for-people-with-copd  Temple Health: https://www.templehealth.org/about/blog/5-ways-maintain-healthy-copd-diet  For more information on medications and oxygen therapy for COPD:  COPD Foundation list of treatments and medication: https://www.copdfoundation.org/Learn-More/I-am-a-Person-with-COPD/Treatments-Medications.aspx    WebMD - What are Treatments for COPD? https://www.webmd.com/lung/copd/what-are-treatments-for-copd   Healthline - COPD Drugs: A List of Medications to Help Relieve Your Symptoms: https://www.healthline.com/health/copd/drugs  COPD Foundation information on oxygen therapy: https://www.copdfoundation.org/Learn-More/I-am-a-Person-with-COPD/Oxygen-Therapy.aspx  American Lung Association information on oxygen therapy: https://www.lung.org/lung-health-diseases/lung-procedures-and-tests/oxygen-therapy 

"People's lives can be changed and [...] the important symptoms they are struggling with can be managed and in many cases, relieved" In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Anne Holland, Professor of Physiotherapy at Monash University and Guest Editor of the Monograph on Pulmonary Rehabilitation. Their broad-ranging discussion covers everything from balancing a home life with a career in medicine, to the impact of COVID-19 on implementing pulmonary rehabilitation. Anne talks about the origins of pulmonary rehabilitation, the need to better personalise patient care, and recommends chapters that will help readers understand the patient experience and that provide practical tips on establishing a rehabilitation programme.

On this episode, rehabilitation assistant Ashley Winter discusses the valuable role of support staff, such as rehab assistants, in pulmonary rehabilitation. The resources mentioned in this episode are: 1) The Canadian Physiotherapy Alliance Description of physiotherapy assistants found here. 2) The British Columbia College of Occupational Therapists Managing support staff practice guidelines found here. I welcome your feedback about the show or idasfor future episodes. You can contact me via the comments section here on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.  

COPD is a lifelong condition, but it doesn't have to be a progressive one. The first and best thing someone can do is to quit smoking. Jan and Jean share their experience giving up cigarettes, and we cover the medications, therapies, and healthy lifestyle changes that can help slow or halt the worsening of lung disease. Plus: what babies, opera singers and harmonica players can teach us about breathing. Visit our website links and resources: HealthUnmuted.com For more information about smoking cessation: COPD Foundation: https://www.copdfoundation.org/ US National Quitline: +1-800-QUIT NOW (+1-800-784-8669) Smokefree.gov: https://smokefree.gov/  Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/tobacco/quit_smoking/index.htm For more information about medications and pulmonary rehab:  COPD Foundation list of treatments and medication: https://www.copdfoundation.org/Learn-More/I-am-a-Person-with-COPD/Treatments-Medications.aspx  COPD Foundation information on pulmonary rehabilitation: https://www.copdfoundation.org/Learn-More/Pulmonary-Rehabilitation/What-is-Pulmonary-Rehabilitation.aspx  WebMD - What are Treatments for COPD? https://www.webmd.com/lung/copd/what-are-treatments-for-copd  Healthline - COPD Drugs: A List of Medications to Help Relieve Your Symptoms: https://www.healthline.com/health/copd/drugs  For more information about patient or pharmaceutical assistance programs:  RxAssist Patient Assistance Program finder: https://www.rxassist.org/  Medicine Assistance Tool: https://mat.org/ Medicare.gov Pharmaceutical Assistance Program finder: https://www.medicare.gov/plan-compare/#/pharmaceutical-assistance-program/states?lang=en&year=2022 American Lung Association list of financial assistance programs: https://www.lung.org/help-support/financial-assistance-programs 

Jonathan Ledyard, Director of Cardiovascular and Pulmonary Rehabilitation at the UPMC Heart and Vascular Institute, joined the podcast to discuss the importance of rehab, telemedicine and his big plans for the future.

On this episode, I talk about several papers which I talked about at the ATS Clinical Year in Review. I refer to a previous episode on Who's Missing from Pulmonary Rehabilitation, which aired on March 17, 2021. The link to that episode is here. Here are the papers I discuss: Lindenauer PK, Stefan MS, Pekow PS, Mazor KM, Priya A, Spitzer KA, Lagu TC, Pack QR, Pinto-Plata VM, ZuWallack R. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among Medicare beneficiaries. JAMA 2020; 323(18):1813-1823. Patel S, Palmer MD, Nolan CM, Barker RE, Walsh JA, Wynne SC, Jones SE, Shannon H, Hopkinson NS, Swee Chin Kon, S, Gao W, Maddocks M, Man WDC. Supervised pulmonary rehabilitation using minimal or specialist equipment in COPD: a propensity-matched analysis. Thorax 2021; 76:264-271. Barker RE, Kon SS, Clarke SF, Wenneberg J, Nolan CM, Patel S, Walsh JA, Polgar O, Maddocks M, Farquhar M, Hopkinson NS, Bell D, Wedzicha JA, Man WD. COPD discharge bundle and pulmonary rehabilitation referral and uptake following hospitalisation for acute exacerbation of COPD. Thorax 2021 Mar 2. doi: 10.1136/thoraxjnl-2020-215464. Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Services Research 2020; 20: 1144.

After 16 months on the front lines of the COVID war in New York at Mount Sinai, Dr Schachter @MountSinaiNYC does not focus on exhaustion or trauma, but rather the possibilities that have come with dealing with such wide-scale and going medical trauma.  Dr. Schachter is currently the Maurice Hexter Professor of Pulmonary and Community Medicine and Medical Director of Pulmonary Rehabilitation at Mount Sinai Medical Center. He has established and directs the Mount Sinai Pulmonary Rehabilitation program. Author of five books and over 400 articles and abstracts on pulmonary disease, Dr. Schachter is past president of the American Lung Association of the City of New York, the Connecticut Thoracic Society and the National Association of Medical Directors of Respiratory Care. He currently serves on the board of directors and as the chairman of the Scientific Advisory Committee of the American Lung Association of the Northeast. In 2005 he was an honoree of the American Lung Association of the City of New York at their annual Life and Breath Gala. In 2016 he received the  from the Lung Association. Dr. Schachter is an advocate for environmental lung issues. He worked with the Southern Poverty Law Center for healthier factory standards and increased workers' compensation for men and women in cotton textile mills. He lobbied for tougher anti-smoking laws in New York City on behalf of the Lung Association and the Coalition for Smoking or Health. He is currently completing a study on the health effects of air pollution on children with asthma in the inner city neighborhoods of New York City. In Schachter's new book, you can learn how to learn strategies to avoid getting pummeled by a cold.

In this episode, I provide a few comments about the interesting research I'm seeing at the American Thoracic Society Scientific Conference. Registration for the conference can be found here.   I mention that I'm also leading Twitter chats related to the posters which are being presented. Follow those chats on the ATS Pulmonary Rehab Assembly which is @PR_assembly and search for the following hashtags: #ATS2021TP101 #ATS2021TP102 #ATS2021TP103 #ATS2021TP104   I mentioned a dynamic graph on rehab and COVID19 which can be found here.    I mention a paper published in the British Medical Journal after COVID19, that paper can be found here.  

Many millions of people suffer from respiratory diseases such as chronic obstructive pulmonary disease, interstitial lung disease and bronchiectasis; and there are Cochrane Reviews for a wide range of interventions that might help, including drugs, devices and physical therapies. These were added to in January 2021 with a new review of the effects of providing pulmonary rehabilitation remotely and we asked the lead author, Narelle Cox from Monash University in Melbourne Australia, to tell us more in this podcast.

Many millions of people suffer from respiratory diseases such as chronic obstructive pulmonary disease, interstitial lung disease and bronchiectasis; and there are Cochrane Reviews for a wide range of interventions that might help, including drugs, devices and physical therapies. These were added to in January 2021 with a new review of the effects of providing pulmonary rehabilitation remotely and we asked the lead author, Narelle Cox from Monash University in Melbourne Australia, to tell us more in this podcast.

Dr. Jill Ohar, a pulmonologist from the Wake Forest School of Medicine joins the podcast to discuss topics in pulmonology in this special edition of the PV Roundup podcast.

In this episode I explain my personal experience, symptoms and recovery from COVID-19 and how it influenced my nutrition and training. Please remember this podcast is not suitable medical advice and is not reflective of everybody's experiences with coronavirus. I share how I listened to my body to tailor my training, and how in hindsight I would have done things different in my rehabilitation and return to run, including a bit more diaphragmatic breathing and yoga. I also share how important it is to continue nourishing your body through a sickness, while also remembering that nutrition is best as a preventative medicine. I discuss the role that Vitamin D, Vitamin C, Magnesium, and Zinc may play in coronavirus and fighting off respiratory infections.   If you find that you struggle with your nutrition during times of adversity, that is exactly why having a nutrition coach can be helpful. From helping you fuel for peak performance, as well as through sickness and injury. Please contact me if you feel you need more support for day to day, or season to season fueling by heading to www.riseupnutritionrun.com. You can always book a free call with me to discuss your needs! Some references & resources reviewed when preparing for this topic include multiple articles from ncbi.blm.nih.gov/research/coronavirus and more specifically: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315835/ Wang TJ, Chau B, Lui M, Lam GT, Lin N, Humbert S. Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769-774. doi:10.1097/PHM.0000000000001505 https://pubmed.ncbi.nlm.nih.gov/32787373/ Zha L, Xu X, Wang D, Qiao G, Zhuang W, Huang S. Modified rehabilitation exercises for mild cases of COVID-19. Ann Palliat Med. 2020 Sep;9(5):3100-3106. doi: 10.21037/apm-20-753. Epub 2020 Aug 10. PMID: 32787373. https://link.springer.com/article/10.1007/s13671-020-00315-0 Matsui, M.S. Vitamin D Update. Curr Derm Rep 9, 323–330 (2020). https://doi.org/10.1007/s13671-020-00315-0

In this talk, I discuss concepts related to who is missing from pulmonary rehabilitation. I mention a study we did in Canada to characterize the pulmonary rehabilitation programs which were running in 2015. The link to that paper is here (https://cts-sct.ca/wp-content/uploads/2018/02/PR-in-Canada-Report_CRJ.pdf)   I also mention a systematic review on several pulmonary rehabilitation survey studies, the link to that paper is here. https://www.tandfonline.com/doi/abs/10.3109/15412555.2014.922066     The Cochrane review I spoke of can be found here: https://www.cochrane.org/CD003793/AIRWAYS_pulmonary-rehabilitation-for-chronic-obstructive-pulmonary-disease and the associated editorial is found here: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.ED000107/full   The link to Dr. Jenny Alison's and Mr. David Meharg's Breathe Easy podcast episode on the American Thoracic Society Pulmonary Rehabilitation Assembly's website can be found here: https://www.thoracic.org/about/ats-podcasts/pulmonary-rehabilitation-for-hard-to-reach-populations-focus-on-indigenous-people.php   I also talk a bit about health inequality in pulmonary rehabilitation in a different American Thoracic Society Breathe Easy podcast, which can be found here: https://www.thoracic.org/about/ats-podcasts/health-inequality-in-pulmonary-rehabilitation.php   If you want to read a bit more about intersectionality and health care, I found this paper published in the Lancet to be very helpful in explaining this complicated concept: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31431-4/fulltext I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

Today on MedNet21, we're going to discuss Cardiac and Pulmonary Rehabilitation.

Nicole Hinkle-Klaus and Shari Deneke with Mary Washington Healthcare visited Town Talk with Ted Schubel to talk about the programs and work of Mary Washington Healthcare Cardiac and Pulmonary Rehabilitation.  They also discussed how to establish heart-healthy habits.Original episode: https://www.newstalk1230.net/episode/town-talk-mw/More about  MWHC Cardiac and Pulmonary Rehabilitation: https://www.marywashingtonhealthcare.com/Our-Services/Heart-Health/Cardiac-Pulmonary-Rehabilitation.aspx

Nicole Hinkle-Klaus and Shari Deneke with Mary Washington Healthcare talk about the programs and work of Mary Washington Healthcare Cardiac and Pulmonary Rehabilitation.  Also talk about how to establish heart-healthy habits.

Josh Miller is a Clinical Associate Professor in the Department of Kinesiology and Nutrition at the University of Illinois Chicago (UIC). Josh joined the UIC faculty in 2019 after working for 5 years at CSU, Bakersfield. Josh also spent several years working in multiple settings – Cardiac and Pulmonary Rehabilitation, research with the VA in … Continue reading Josh Miller DHSc University of Illinois Chicago (UIC) →

Learning on the job: Creating a plan for your professional development in pulmonary rehabilitation   In this episode, I talk about planning your professional development.   I mention Table of Contents alerts for journals. Some suggestions are:  European Respiratory Journal ToC sign-up https://erj.ersjournals.com/alerts Annals of the American Thoracic Society ToC sign-up. [select: ‘eToC Alerts'] https://www.atsjournals.org/toc/annalsats/current Physical Therapy ToC sign-up. [select ‘Email Alerts'] https://academic.oup.com/ptj Journal of Cardiopulmonary Rehabilitation and Prevention ToC sign-up. [select: ‘get new issue alerts'] https://journals.lww.com/jcrjournal/pages/default.aspx Thorax ToC sign-up. [select ‘Email alerts'] https://thorax.bmj.com/   I mention podcasts in this episode. Some suggestions are: Katie Linder has a podcast series dedicated to people in academia. You can learn more about them here: https://www.drkatielinder.com/podcasts/ The Physical Therapy journal used to have the Craikcast, which I enjoyed but can't easily find it online. They do have the PTJ Podcast which can be found here. https://academic.oup.com/ptj/pages/podcasts The American Thoracic Society has several podcasts, which can be found here. https://www.thoracic.org/professionals/all-ats-podcasts.php The ‘White Coat, Black Art' podcast can be found here. https://www.cbc.ca/listen/live-radio/1-75-white-coat-black-art   I mention the American Thoracic Society Pulmonary Rehabilitation Assembly, the link to the Assembly can be found here: https://www.thoracic.org/members/assemblies/assemblies/pr/   I mention the previous LungFIT episode on starting a journal club. The link to that episode is here.

In this episode, I discuss Patient-Reported Experience Measures, or PREMs. This is a continuation of the previous episode, in which I talk about Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs).  The previous episode on PROs and PREMs can be found here: https://lungfit.med.ubc.ca/pros-proms-what-are-they-the-dyspnea-example/ In this episode, I talk about the Canadian Institute of Health Information and their work with PREMs. More on this can be found here: https://www.cihi.ca/en/patient-experience/about-the-canadian-patient-experiences-survey-on-inpatient-care

In this podcast Dr. Janaudis-Ferreira, Dr. Allison and Mr. Meharg discuss the burden of chronic respiratory disease on indigenous people, the evidence of pulmonary rehabilitation in this population and how to develop a culturally safe pulmonary rehabilitation program.

In this podcast, Dr. Pat Camp and Dr. Claire Nolan discuss health inequality in pulmonary rehabilitation and how we can work differently to address these issues.

In this episode, I provide a brief overview of the history of pulmonary rehabilitation.   I mention several papers in this episode. Several of them are open-access:   Celli BR, Goldstein RS. A historical perspective of pulmonary rehabilitation. In: Clini E, Holland AE, Pitta F, Troosters T, eds. Textbook of Pulmonary Rehabilitation. Springer, 2018. Denison C. Exercise and Food for Pulmonary Invalids. Available from Amazon: https://www.amazon.com/Exercise-Pulmonary-Invalids-Classic-Reprint/dp/B008C4AT8E. Petty TL, Nett LM, Finigan MM, Brink GA, Corsello PR. A comprehensive care program for chronic airway obstruction. Annals of Internal Medicine 1969; 70(6):1109-1120. https://pubmed.ncbi.nlm.nih.gov/5789505/ Barach AL. A Treatment Manual for Patients with Pulmonary Emphysema. New York, NY: Grune & Stratton, Inc.; 1969. Hodgkin JE, Balchum OJ, Kass I, Glaser EM, Miller WF, Haas A, Shaw DB, Kimbel P, Petty TL. Chronic obstructive airway diseases. Current concepts in diagnosis and comprehensive care. JAMA 1975; 232:1243–60. https://jamanetwork.com/journals/jama/article-abstract/336862 Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982; 284:1607–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1498516/ Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773–8. https://thorax.bmj.com/content/thoraxjnl/42/10/773.full.pdf Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992 ;145:1321–7. https://pubmed.ncbi.nlm.nih.gov/1595997/ Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47:1019–24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1021093/ Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet 1994; 344:1394–7. https://pubmed.ncbi.nlm.nih.gov/7968075/ Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS, Koeter GH. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J 1994; 7:269–73. https://pubmed.ncbi.nlm.nih.gov/8162979/. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122:823–32. https://pubmed.ncbi.nlm.nih.gov/7741366/. Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:442–7. https://pubmed.ncbi.nlm.nih.gov/8756820/ Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; Oct 18;(4):CD003793. https://pubmed.ncbi.nlm.nih.gov/17054186/ McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2:CD003793. https://pubmed.ncbi.nlm.nih.gov/25705944/     I welcome your feedback about the show or ideas for future episodes. You can contact me via the comments section on the LungFIT website. If you listen to the LungFIT podcast on iTunes, please take a moment to review the show. Click here to be directed.

So much about the COVID-19 era feels unpredictable and beyond our control. But, the research analysis covered in this course will open your eyes to some ways where we can be extremely helpful. Not only can you use your occupational therapy skills to help patients in acute care, but you can even help those who are home with mild symptoms.I know we say this at OT Potential a lot, but your skill set is desperately needed.The course will begin with a breakdown of some current research on COVID. Then, Torrie Niewoner, an occupational therapist who treats patients with COVID-19 in the inpatient setting, will join us to discuss practical takeaways.In order to earn credit for this course, you must take the test within the OT Potential Club.You can find more details on this course here:https://otpotential.com/ceu-podcast-courses/covid-ot-ceuHere's the primary research we are discussing:Wang, Tina J. MD; Chau, Brian MD; Lui, Mickey DO; Lam, Giang-Tuyet MD; Lin, Nancy MD; Humbert, Sarah MD Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19, American Journal of Physical Medicine & Rehabilitation: September 2020 - Volume 99 - Issue 9 - p 769-774Support the show (https://otpotential.com/ot-potential-club)

In this podcast, Dr. Patel gives an overview of the pediatric cardiopulmonary rehabilitation program at Nationwide Children's Hospital in Columbus, OH. Dr. Patel explains the advantages of this novel approach to children with acute and chronic respiratory illnesses and she also provides insight into the future directions in this exciting and evolving field.

On this episode, I talk about COVID-19 and pulmonary rehabilitation, including questions that health care professionals should ask themselves when they consider admitting patients who have had COVID-19 and ongoing symptoms. I mentioned some papers that I would recommend reading, that discuss some of these questions in more detail, as well as provide guidance to you as you consider caring for patients who have had COVID-19, in your pulmonary rehabilitation programs. Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.02197-2020). This paper can be found here.   American Thoracic Society Assembly on Pulmonary Rehabilitation. “Guidance for Re-opening Pulmonary Rehabilitation Programs.” This paper can be found here.   American Physical Therapy Association Webinars on “Physical Therapy Considerations of COVID-19 in the Post-Acute Setting” aired on April 18, 2020 and “COVID-19: Clinical Best Practices in Physical Therapy Management”, aired on March 28, 2020. These webinars can be found here.

This month's Journal Club podcast dives deeper into a COVID-19 article published in AJPM&R's September 2020 issue. Our host Eric Wistozky, MD, joined by Dain Thorpe, MD, interviews Tina Wang, MD, Assistant Professor of PM&R at Loma Linda University in Loma Linda, CA. Dr. Wang offers recommendations to bring PM&R perspectives and interventions to the multidisciplinary treatment of COVID-19, particularly in the area of pulmonary rehabilitation. You can read the full article, published in AJPM&R, here: https://journals.lww.com/ajpmr/Fulltext/2020/09000/Physical_Medicine_and_Rehabilitation_and_Pulmonary.1.aspx.

Celeste Kolanko, Managing Director at Liberum IME, will be joined by Kirk Lanzone Terry, a Chicago-based international medical education professional who has served in several roles for non-profit societies such as The International Parkinson & Movement Disorder Society and The American Association of Cardiovascular & Pulmonary Rehabilitation. Currently he serves as the Director of Education and Operations for The American Society for Transplantation and Cellular Therapy.

 Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians | Does Pulmonary Rehab Save Lives after COPD Hospitalizations? JAMA May 12, 2020 | Not Medical Advice or Opinion Lindenauer PK, Stefan MS, Pekow PS, et al. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA. 2020;323(18):1813–1823. doi:10.1001/jama.2020.4437 Rochester CL, Holland AE. Pulmonary Rehabilitation and Improved Survival for Patients With COPD. JAMA. 2020;323(18):1783–1785. doi:10.1001/jama.2020.4436  

THE EXPERT SECRETS RADIO SHOW FREE NOTES. Today I have 2 free videos + new physical health frameworks. Go to this web page and enter your email and you have instant access. Scroll down the page to the episode for today.https://expert62e801.clickfunnels.com/expertHERE IS WHAT I WILL COVER IN TODAY’S SHOW….# GOOGLE CLASSROOM HACK...HOW TO VOICE TYPE ON A GOOGLE DOC.# HOW TO DOWNLOAD A YOUTUBE VIDEO AND POST IT TO YOUR GOOGLE CLASSROOM.# WHAT IS THE NUMBER # 1 WAY TO CREATE PHYSICALLY HEALTHY STUDENTS ONLINE?Also, in today's episode you will hear from one of my Super EXPERT PhDs in his own voice. Barry A. Franklin is Director of the Cardiac Rehabilitation Program and Exercise Laboratories, William Beaumont Hospital, Royal Oak, Michigan, and Professor of Physiology, Wayne State University, School of Medicine, Detroit, Michigan. He is the past Editor-in-Chief of the Journal of Cardiopulmonary Rehabilitation and Prevention and the American Journal of Medicine & Sports, and is a past president of the American Association of Cardiovascular and Pulmonary Rehabilitation (1988) and the American College of Sports Medicine (1999). Currently, he holds formal editorial board appointments with 15 different scientific and clinical journals, including the American Journal of Cardiology, Chest, Preventive Cardiology, Medicine and Science in Sports & Exercise, American Journal of Health Promotion, and the American Journal of Lifestyle Medicine. He is also the current chair of the American Heart Associations’ Council on Nutrition, Physical Activity, and Metabolism. Dr. Franklin and his associates have studied the hemodynamic and cardiorespiratory responses to numerous occupational and leisure-time activities. Other areas of research interest include the primary and secondary prevention of heart disease and the risks associated with sporadic, high-intensity exercise. Dr. Franklin has written or edited more than 500 publications, including 375 papers, 77 book chapters, and 27 books.Enjoy!!!THE EXPERT SECRETS RADIO SHOW FREE NOTES. Today I have 2 free videos + new physical health frameworks. Go to this web page and enter your email and you have instant access. Scroll down the page to the episode for today.https://expert62e801.clickfunnels.com/expert

This week on Rural Health Leadership Radio, we’re talking about pulmonary and cardiac rehabilitation. We’re having that conversation with Tracy Conroy, CEO, Valerie Roark, Director of Cardiopulmonary Services, and Connie Wilson, Cardiac/Pulmonary Rehabilitation Nurse at Daviess Community Hospital. “Don’t let fear of the unknown keep you from seeking the care and the treatment and talking to your physician about what you can do to improve your lifestyle.” ~Tracy Conroy Tracy Conroy has over 25 years of leadership experience in both acute and long-term care, population health management, outpatient clinics, and regional partnerships. She is very knowledgeable about patient experience, revenue growth, patient quality and safety, physician recruitment, and capital construction. Tracy is also an active member of the Indiana Rural Health Association, Rotary Club of Washington, IN., American Red Cross, and serves on the Board of Directors for the Daviess County Economic Development Corporation.  Tracy is passionate about expanding access to care for all residents and collaborating with the community to promote positive health outcomes.  “Having programs like Pulmonary Rehab is what gives me hope because I know that the patients that come into pulmonary rehab and that really embrace what we teach in there, that it’s life-changing for them.” ~Connie Wilson Connie Wilson MSN, RN, CCRP, CCEP, Certificate in Pulmonary Rehabilitation currently serves as the Cardiac/Pulmonary Rehabilitation nurse at Daviess Community Hospital. She has been a nurse for 34 years, with 28 years in Cardiac Rehabilitation and 25 years in Pulmonary Rehabilitation. Connie is an active member of the Indiana Society of Cardiovascular and Pulmonary Rehabilitation, being on the board of directors and serving as President in 2007 and 2018. “There’s hope on the horizon that people will live a better quality of life as they progress through the phases of COPD.” ~Valerie Roark Valerie Roark is a Registered Respiratory Therapist working with Daviess Community Hospital in Washington, IN for the past 30 years as the Director of the Cardiopulmonary Department, EEG's, Sleep Diagnostics and Cardiac and Pulmonary Rehabilitation. She feels she has positively impacted the Daviess Community Hospital and the community it serves by raising the level of professionalism within the departments she provides oversight by recruiting and hiring highly-skilled, passionate, caring professionals whether it be respiratory therapists, registered nurses or in our most recent hire of exercise physiologists for our cardiac and pulmonary rehab programs.

UK Accreditation Scheme for Pulmonary Rehabilitation

In this episode, Tracy, Valerie, and Connie discuss Daviess Community Hospital’s pulmonary rehab program and how it started, what they have learned so far in the three years of their program, COPD from both a patient and hospital aspect, and the future of COPD care. Daviess Community Hospital is a 74-bed, non-profit hospital in Washington, Indiana with an extensive pulmonary rehabilitation program. Tracy Conroy serves as the chief executive officer and provides operational, financial, and strategic leadership that supports the mission and vision of Daviess. She has over 25 years of leadership experience in both acute and long-term care, population health management, outpatient clinics, and regional partnerships. Valerie Roark is a Registered Respiratory Therapist working with Daviess Community Hospital for the past 30 years as the Director of the Cardiopulmonary Department, EEG's, Sleep Diagnostics and Cardiac and Pulmonary Rehabilitation. Connie Wilson is currently the Cardiac/Pulmonary Rehabilitation nurse. Connie has been an RN for 34 years with 28 years in Cardiac Rehabilitation and 25 years in Pulmonary Rehabilitation.

Update of Reimbursement and Educational Curriculum for Pulmonary Rehabilitation in The United States

In this podcast, Christian Osadnik, PhD, discusses his team's latest research on the effects of pulmonary rehabilitation programs on comorbid depression and anxiety in patients with chronic obstructive pulmonary disease. More at: www.consultant360.com/pulmonology.

Christian R. Osadnik, PhD, joins CHEST Podcast Editor, Dominique J. Pepper MD, MBChB, MHSc, to discuss the effect of pulmonary rehabilitation on symptoms of anxiety and depression in patients with COPD.

Chronic obstructive pulmonary disease, or COPD, has skyrocketed over the past 35 years. Dr. Matthew Schreiber discusses what it means for D.C., and how you can be as healthy as possible if you have the disease.   TRANSCRIPT Intro: MedStar Washington Hospital Center presents Medical Intel where our healthcare team shares health and wellness insights and gives you the inside story on advances in medicine. Host: Thanks for joining us today. We’re talking to Dr. Matthew Schreiber, associate director of the Medical ICU and an attending physician in Pulmonary Disease/Critical Care Medicine at MedStar Washington Hospital Center. Welcome, Dr. Schreiber. Dr. Schreiber: Well, thank you for having me. Host: Today we’re talking about a September 2017 report that showed that the number of Americans who died from chronic respiratory diseases, particularly chronic obstructive pulmonary disease known as COPD, skyrocketed over the past 35 years. In 2014, 53 people out of every 100,000 died of a chronic respiratory illness, up from 41 in 1980, a 31% spike. 85% of those deaths were from COPD, which is now the third leading cause of death in the U.S. Dr. Schreiber, how does Washington, DC compare to the national rates of chronic respiratory diseases and COPD? Dr. Schreiber: Well, Washington DC, if you were to just look at it as a city, it’s doing great. The CDC and the NIH did a report starting in 2011 that talks about state by state, how much COPD is there, and I think when you’re talking about chronic respiratory diseases, COPD is really kinda the marker for what you’re talking about. There are a ton of different things that are chronic diseases in the lung, but the biggest bulk of them is going to be COPD, and even if someone had asthma their whole life, they can later have COPD, because of the chronic nature of that destructive disease.  Coming back to what you asked, DC is ranking in with only 4.6% of its residents having COPD and that’s actually pretty darned good, if you look at our neighboring states. It’s 5.9% in MD; 6.1% in VA; and 8.9% in WV. If you dive into the data a little bit deeper though, DC is a tale of two cities. There are a number of things that the CDC and the NIH found had associations with being diagnosed with COPD, and what they found was that in Washington, you had 2.1% of white respondents saying they had COPD, but up to 6.7% in the African American population, and they didn’t report on other ethnic backgrounds. So, 4.6 sounds awfully nice, it’s at the low end of the national levels, but then when you start breaking that down, there are definitely some groups in our district who are suffering from this condition, uh, at higher than average levels for the nation. If you look at people who are unable to work, and this might be because of their lung disease, but, of course, being unemployed can have any number of reasons—19.9% of folks that were unable to work reported being diagnosed with COPD. If you had less than a high school education, 9.6%. Nearly 1 out of 10 people with less than a high school education had been diagnosed with COPD, and age was a big factor. If you looked at folks 18-44, it’s down to 2.2%, but once you’re over 75, almost 10. So, even though you could say we’re doing great, being at the low end of the national level, we’ve got some work to do. Host: Why would there be such disparity between the education and the types of work that people are doing? Is there some kind of a cause environmentally? Dr. Schreiber: COPD is a condition that no one can say they know absolutely what causes it. There’s a number of theories behind it. What I can tell you is COPD is exactly what the name says. It’s chronic, so once you have it, you have it. It doesn’t get cured, it doesn’t go away, it might not progress very fast, but you have it, and it’s all about obstruction. The ‘O’ in the name says the whole thing. People with COPD have trouble moving the air in and out of their chest. And so, if you can’t move the air out, and you’re trying to do some activity or exercise, the faster you’re breathing, the more air that you’re breathing in that you can’t then get out, and you get short of breath. And it’s pulmonary disease, lung disease. So, if you look at it as a pure aspect like that, this could be caused by inhaling something that can damage your lungs over and over again. Cigarettes are the model example for that, and in truth, this seems like common knowledge to a lot of people now, it’s new. We didn’t have studies that showed cigarettes caused things like lung cancer until the 1950s. And we didn’t have a surgeon general’s warning about the damages of smoking until the 1960s and 70s, so progress has been made. But you’ve got a lot of history in the United States with tobacco use and tobacco exposure, and a lot of science going into cigarettes since the early 1900s, that have done its job, so to speak, on getting people to use cigarettes, and the consequences of that use, that we’re only now seeing. When you think about other types of inhaled irritants, different jobs can cause different problems. I ask in my clinic all the time, ‘What kind of work have you done through your whole life?’ And people will focus on the things they might have enjoyed or liked and then I always come back, ‘Did you ever do anything that was around smoke, around fires, around a lot of chemicals, around inhaled irritants where you had to wear a mask, or maybe wish you had worn a mask?’ And people will think about what they did earlier in their life. And the lungs are remarkable things. We have “extra,” so to speak, that when you look at the lifelong duration of how much lung function you have and when it would have to get low enough to cause symptoms, we’re all, for the most part, born with enough lung and develop enough into our late teens early twenties that we can all fortunately die of something else before our lungs become an issue. But when you have these exposures or even some people who just have genetics that predisposes their lungs to dropping off function faster than the average person, when you get to later in life, you start to have this obstruction and then these symptoms, and that’s where people come in and we make this diagnosis. Host: What can a person do to reduce their risk for COPD? Dr. Schreiber: Quit smoking. That’s clearly from a research based standpoint, the thing that can have the greatest impact on reducing your risk. If you have a strong family history, you know, ‘both my parents and one of my brothers has been diagnosed with COPD.’ If that’s your story, you can talk to your professionals in your clinics and your primary care, uh, centers to say, ‘Is there anything that I should be tested for because it seems like everyone in my family is getting COPD or getting it at a young age,’ or ‘I have a non-smoker in my family who’s been told they have COPD.’ They’re a deficiency; something called alpha-1 antitrypsin. Incredibly rare disease, but important enough because of how it gets passed along in families that it’s something you can consider having testing for if it seems like there’s a higher than average risk for COPD in your family. Um, if you are in a career path or a job that gives you a lot of, what we call occupational lung exposure - you’re around something where you’re just breathing in things that seem to irritate you all the time, or, you know, in the back of your head, you’re just saying ‘Gosh, I’m breathing a lot of this stuff,’ it’s…it’s worth it to come talk to your primary care physician or if you have a pulmonologist you can see otherwise, to talk about your risks and being tested. The American Academy of Family Practitioners recommends that anyone who has ever smoked, meaning 100 cigarettes in their life, so the, ‘Well, I only have a cigarette or two if I’m out on the weekends at the bar,’ well that only takes two years of weekends before you’ve had a hundred cigarettes. Host: That’s five packs. Dr. Schreiber: There ya go! And a cough should be tested because we want to catch people early in COPD so we can both manage their symptoms and encourage them to make lifestyle changes that will hopefully not let the disease progress. Host: So, you talked about some disparities in education and across the work force. Who’s most at risk for developing chronic respiratory diseases and COPD? Dr. Schreiber: The research shows that far and away the most at risk are still going to be the smokers. Now the question is, who becomes the smokers? There are a number of scholars that have looked into the impacts of tobacco on public health. So, they point out that there’s a disproportionate, meaning a lot more than you’d expect, of advertising for tobacco products in poor neighborhoods. Their arguments that things like menthol cigarettes are targeted at particular socioeconomic or racial backgrounds and advertising has been done in a way to actually target different groups. Now, these are all theories. I…I can’t overtly say there’s proof, but, I think if you walk around a neighborhood that may be lower on the socioeconomic scale, and walk around a very affluent neighborhood, you will notice there are more billboards in some than others, that there are more advertisements on your corner store for cigarettes than in others, and in fact, this has gotten to the point where laws had to be passed about advertising cigarettes in certain proximities to schools and daycares, because of how it seems that there’s not only this risk of socioeconomics and education having to do with developing COPD and as a proxy of that, maybe using tobacco products, but also the way that marketing is being applied because of how those populations are vulnerable when more people may have this condition and smoking and you add fuel to the fire. So, it is a bigger question of social structure than I think I could ever answer, but there are a lot of people very interested in why these disparities are there. Host: If a person has smoked in the past and they quit, maybe they quit ten years ago, or they used to work in a chemical plant or a place where they’re exposed to smoke, is there anything particular that they can do to either be screened or to reduce the effects of that damage? Dr. Schreiber: Being screened, absolutely. The only way to diagnose COPD is with something called spirometry. It’s a breathing test. It’s looking for that obstruction. We have someone basically blow into a tube connected to a small computer, and we see how much air came out and how much came out in the very first second.  Because someone with COPD, they can get all the air out, they just can’t do it quickly, and if I asked you to blow out for the six seconds it takes for that test and you have normal lungs, it’s hard.  Like at the end you’re really trying to push out that last bit. People that have obstructions, I’ve read results from these tests and they’re still breathing out at 13, 14, 15 seconds because that’s how long it takes to get the air out because of the slowness of it. You can’t diagnose COPD with a cat scan, an x-ray, a stethoscope, a physical exam, a history – unfortunately, that still happens all the time. In the NIH/CDC data talking about COPD in all these different states, DC for example - three out of ten people reported never having had spirometry, yet were given a diagnosis of COPD. I would bet they probably have it based on the symptoms they had, but there are other things that could be going on and getting tested with spirometry, which can be done in the clinic, you don’t necessarily have to get what we call full pulmonary function tests which are done in the hospital, um, not as an admitted patient, but just in…in our hospital facilities, to get some of that answered. And a number of primary care clinics can do spirometry in the office. Um, we can do it in our pulmonary clinic, if that’s all the information we need. Or we can send people for additional testing with full pulmonary function tests. What can somebody do to slow the effects? That’s the tough part. There was a…a landmark study that gets talked about all the time in healthcare where a group of researchers developed a diagram showing the natural history of what happens to lungs. It’s called the Fletcher Peto Curve. And, what they showed is that for a person with no lung disease, we have our best lungs at about 20-25 years old. And then it’s literally all downhill from there. For somebody who has vulnerable lungs and has that bit of damage happening from smoking or whatever their particular cause is, if they can get away from that or quit smoking or get rid of that damaging effect, their lungs never grow back. The lungs aren’t like skin and muscle and bones. You kinda have what you have after the age of 25, but the rate of decline slows down. And so, you ask…started off this conversation saying, ‘Where is this large uptick in COPD coming from?’ It’s coming from us finally recognizing what’s been going in a lot of people for probably the last twenty or thirty years. If you look at that Fletcher Peto graph and you say, ‘Well ok, if a 50-yr. old quits smoking at age 50, they might not get bad enough lungs to have symptoms until they’re 75.’ It doesn’t mean they didn’t have COPD at 50, just wasn’t causing them disability where they actually might have gone in and gotten tested for it.  If you have someone who’s 73 and maybe has no symptoms because they’re one of those people that you’ve met that smoked their whole lives and did fine, then in 2 years later they start having lung problems, they had COPD all along. It’s just they got so close to that symptom marker that now, you know, a year after they quit, they’re on oxygen or can’t go up the three steps to go in their house, and in truth, that’s the scary thing. I don’t understand the response sometimes from patients but they’ll say something like, ‘Well, I’m not worried because this family member, uh, did well with this or did well with that, and so I’m not worried about smoking.’ But it’s not about necessarily the death with COPD, it’s the disability.  Losing your independence and…and I’ve met people in my clinic who literally get short of breath eating. Taking a shower leaves them winded, and that’s the kind of life changing event that is so horrible about COPD, that it takes away your freedom. And, people surveyed in DC talking about how COPD has affected them, almost 2/3 said they have some kind of exercise limitation because of breathing, and that’s why we need people to get checked early, to hopefully get them to either start medication to prevent flare-ups and exacerbations or maintain their symptoms under control, or to make lifestyle changes that might slow the progression. Host: How do you go about addressing that risk with your patients? Dr. Schreiber: I spend a lot of the time counseling smoking cessation, and encouraging activity, referring people to something called Pulmonary Rehabilitation, which is different from just physical therapy because they’ll have respiratory therapists and people that are trained on ways you can manage your breathing a little bit better and how to push your limits but not get exhausted, to still make progress. We talk about nutrition, and keeping people physically fit and being preventative, like getting vaccinations where they’re appropriate. Um, so there’s a lot of things when someone has COPD that we can offer them or counsel them to try to keep them as healthy as possible. Medications have been shown to help when you have COPD. And, it’s an interesting split to me and…and I say this to my patients in the clinic all the time - you wouldn’t wait until you’re having a heart attack or a stroke to start taking your blood pressure medicine, even though you feel fine. For some reason with inhalers people say, ‘Well, I’m breathing ok so why am I taking this inhaler every day?’ But these are preventive medicines, and if I can stop you from having a flare-up this year, which then will affect your lung function next year, that’s a win.  And so, the things that we prescribe in the pulmonary clinic are not always just to make you feel better, they’re also to prevent you from falling apart in some way, because nature is still going to cause those lungs to decline a bit, but if I can NOT have you in an urgent care or hospital with something that’s gonna make it decline even faster, to then keep you independent and doing things, even though you quote ‘feel like you’re breathing ok,’ then I’m doing my job. Taking a pill for folks just seems to be simpler than using an inhaler, and granted, there’s a lot more coordination going on with using an inhaler, and a lot of people use them wrong, and there’s no point in medicating the back of your throat when we need it to get it down into your lungs.  But, it’s another task in the day that takes a few more seconds than just swallowing something with water and, you know, it’s something that I think when you look at a patient and they’re using an inhaler, there might be social or, you know, other biases where you look at them and say, ‘Oh, you’re doing that, as compared to just discretely swallowing a pill with a glass of water.’ And so, I think a lot goes into it. Um, it also comes back to that idea of ‘well why am I taking this medicine if it’s not making me feel better?’ And, with the way that our society, uh, has a healthy and appropriate fear of heart disease and strokes and diabetes and hypertension, um, medications for those, I think, are something people buy into and I don’t think we’re there yet with breathing disorders to say, ‘This is something that you really should do and here are the risks and here are the dangers and here’s why.’  I think, in some ways, that’s a…a blessing, that this is a new enough common disease, so to speak, that we’ve only been dealing with this for forty or fifty years, um, that people don’t have a hundred years of being afraid of heart attacks and strokes the way that, uh, they don’t necessarily have that fear with COPD, but it means we’ve got a lot of catching up to do really quickly. Host: Thank you for joining us today, Dr. Schreiber. Dr. Schreiber: No, it’s been my pleasure. Thank you. Conclusion: Thanks for listening to Medical Intel with MedStar Washington Hospital Center. Find more podcasts from our healthcare team by visiting medstarwashington.org/podcast or subscribing in iTunes or iHeartRadio.

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the evidence for pulmonary rehabilitation for COPD and highlight the need for more publicity for its benefits. Read the editorial here: http://dtb.bmj.com/content/56/5/49. The editors also review the evidence for safinamide for Parkinson’s disease (http://dtb.bmj.com/content/56/5/54), and discuss the use of bezlotoxumab, a monoclonal antibody licensed for the prevention of recurrence of Clostridium difficile infection in adults who are at high risk of recurrence (http://dtb.bmj.com/content/56/5/57).

Dr. Jonathan Whiteson is Assistant Professor, Department of Rehabilitation Medicine; Assistant Professor, Department of Medicine; Medical Director of Rusk Outreach and Growth; and Medical Director of Cardiac and Pulmonary Rehabilitation. His research interests include: cardiac rehabilitation for patients with advanced congestive heart failure and after left ventricular assist device placement, pulmonary rehabilitation of individuals exposed to world trade center dust, and recognizing encephalopathy and delirium in the cardiopulmonary rehabilitation setting. His medical degree is from the University of London and he completed his residency at NYU Medical Center in Physical Medicine and Rehabilitation where he also completed a fellowship in cardiac and pulmonary rehabilitation. He is certified by the American Board of Physical Medicine and Rehabilitation.  This is the second of a two-part series with Dr. Whiteson in which he discusses many topics including: conditions such as medically complex, cardio-pulmonary, stroke, or TBI that make it more likely that a patient could become a candidate for readmission within 30 days of being discharged; challenges in treating frail patients; a pilot program at Rusk that involves patient needs assessment, medication reconciliation, patient education, making arrangements for out-patient/home-based services, and telephone follow-up; what is being done at Rusk from the standpoint of educating family caregivers and viewing them as valuable members of the health care team; how the Rusk team does an assessment of the safety of a patient's home to lower the risk of falls; and problems associated with polypharmacy that need to be taken into account when providing rehabilitation care.

Dr. Jonathan Whiteson is Assistant Professor, Department of Rehabilitation Medicine; Assistant Professor, Department of Medicine; Medical Director of Rusk Outreach and Growth; and Medical Director of Cardiac and Pulmonary Rehabilitation. His research interests include: cardiac rehabilitation for patients with advanced congestive heart failure and after left ventricular assist device placement, pulmonary rehabilitation of individuals exposed to world trade center dust, and recognizing encephalopathy and delirium in the cardiopulmonary rehabilitation setting. His medical degree is from the University of London and he completed his residency at NYU Medical Center in Physical Medicine and Rehabilitation where he also completed a fellowship in cardiac and pulmonary rehabilitation. He is certified by the American Board of Physical Medicine and Rehabilitation.  This is the first of a two-part series with Dr. Whiteson in which he discusses many topics including: conditions such as medically complex, cardio-pulmonary, stroke, or TBI that make it more likely that a patient could become a candidate for readmission within 30 days of being discharged; challenges in treating frail patients; a pilot program at Rusk that involves patient needs assessment, medication reconciliation, patient education, making arrangements for out-patient/home-based services, and telephone follow-up; what is being done at Rusk from the standpoint of educating family caregivers and viewing them as valuable members of the health care team; how the Rusk team does an assessment of the safety of a patient's home to lower the risk of falls; and problems associated with polypharmacy that need to be taken into account when providing rehabilitation care.

Recorded at the Birdman Studio. In this episode Birdman chats with Millie Walat and Julie Jackson, both RNs (Registered Nurses) who work with Summit Healthcare's Cardiac Pulmonary Rehabilitation Center.    Video @ https://youtu.be/cG8uQlfwNRE   What is Cardiac Pulmonary Rehabilitation? Cardiac Pulmonary Rehabilitation is to help people who have a history of or are at risk for heart disease (cardiovascular disease) or are living with lung disease (pulmonary disease). People with heart disease can improve their health and reduce their risk of future cardiovascular disease, medical complications, and future hospitalizations. People with lung disease can learn to manage their disease well and reduce the risk of hospitalization.  The programs offered are designed to support a patient’s physical, emotional and social needs and include support for their families. Summit Healthcare CardioPulmonary Rehabilitation programs serve Northeastern Arizona and use the guidelines of the American Association of Cardiovascular and Pulmonary Rehabilitation. These programs include a specialized plan of care developed by our team of experienced, advanced life support certified, registered nurses and licensed respiratory therapists.     For more information visit: https://summithealthcare.net/cardiac-pulmonary-rehabilitation Cardiac and Pulmonary Discussion Group that meets every Wednesday from 12:30 pm - 1:30 pm, family members are invited. To learn more about our CardioPulmonary Rehabilitation Services call 928.532.1150. Summit Healthcare serves Show Low, Snowflake, Pinetop-Lakeside, and surrounding areas in Arizona.  

Have you or a loved one experienced a cardiac event? If so, your physician may prescribe cardiac rehab.  According to the American Heart Association, cardiac rehabilitation programs can "extend overall survival" and "improve quality of life" for those with coronary disease. St. Luke's Cornwall Hospital's Center for Cardiac Rehabilitation has earned the Distinction of Excellence from the American Association of Cardiovascular and Pulmonary Rehabilitation, ensuring patients that they are receiving the best care in the region.In this podcast, Murray Low, EdD., MAACVPR, FACSM, FAACVPR, Director, Cardiac Rehabilitation, Burke Rehabilitation Hospital, joins the show to share what you can expect if you or a loved one is prescribed cardiac rehab.

ATS 2017 - Highlights of the assembly on Pulmonary Rehabilitation

Recorded at Birdman Media Studio. In this episode Birdman chats with Ken Allen, Chief of Physician Services and new position, Executive Director of the NEAR (Northeastern Arizona Regional) Care Team with Summit Healthcare Regional Medical Center. Video @ https://youtu.be/Dy8_bDlqjaU   About Ken Allen: Ken Allen has been a member of the Summit Healthcare Administration since 1995. Responsibilities include leadership for Summit Healthcare’s sponsored physician network, Summit Healthcare Medical Associates. Ken’s goal is to improve access to and availability of healthcare services for residents of the White Mountain Communities. Professional memberships have included American College of Healthcare Executives, Health Care Compliance Association, American College of Sports Medicine, American Association for Cardiac and Pulmonary Rehabilitation, and the Fellowship of Christian Athletes. In 2006 and 2015 Ken was recognized by the Arizona Hospital and Healthcare Association as a Leadership Fellow.   Visit https://summithealthcare.net/  

An introduction to genomics in COPD and pulmonary rehabilitation

Jennifer K. Quint, PhD, and editorialist Michael C. Steiner, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the observational analysis of recorded referral for pulmonary rehabilitation in relation to subsequent healthcare utilization for acute exacerbation of COPD.    

Delivering pulmonary rehabilitation with minimal resources, with Drs Jenny Alison and Zoe McKeough.

2016 ATS Pulmonary Rehabilitation Assembly Podcast: Measuring outcomes of pulmonary rehabilitation

A multidisciplinary approach to pulmonary rehabilitation

ATS Podcast on pulmonary rehabilitation in non-obstructive lung disease

Among the various types of interstitial lung diseases, idiopathicpulmonary fibrosis (IPF) is the most common disorder and has a poorprognosis and a limited response to pharmacological treatment. Inpatients with IPF, functional exercise tolerance and quality of lifehave been shown to be significantly decreased. Current IPF guidelinessuggest only a weak recommendation for pulmonary rehabilitation (PR).However, PR is regarded as a reasonable choice for the majority ofpatients with IPF. This review will summarize all of the availablestudies that have investigated the effects of PR in patients with IPF sofar. Although only a small number of studies have been published todate, most studies have found significant short-term improvements infunctional exercise capacity, quality of life, and level of perceiveddyspnea. Long-term improvements or maintenance strategies of PR in IPFpatients have not been adequately investigated yet. Up to now there isstill no sufficient evidence for the recommendation of PR in IPF.However, physical training seems to be the major component of all PRprograms. The current review will discuss potential exercise trainingregimens for patients with IPF and suggest additional useful modalitiesof a specific multidisciplinary PR program for IPF patients. Based onthe current literature and our own experience, this article will try tohighlight the importance of PR as an additional, beneficial therapeuticoption for patients with IPF.

Background: Pulmonary rehabilitation is a well-recognized treatment option in chronic obstructive lung disease improving exercise performance, respiratory symptoms and quality of life. In occupational respiratory diseases, which can be rather cost-intensive due to the compensation needs, very little information is available. Objectives: This study aims at the evaluation of the usefulness of pulmonary rehabilitation in patients with occupational respiratory diseases, partly involving complex alterations of lung function and of the sustainability of effects. Methods: We studied 263 patients with occupational respiratory diseases (asthma, silicosis, asbestosis, chronic obstructive pulmonary disease) using a 4-week inpatient rehabilitation program and follow-up examinations 3 and 12 months later. The outcomes evaluated were lung function, 6-min walking distance (6MWD), maximum exercise capacity (Wmax), skeletal muscle strength, respiratory symptoms, exacerbations and associated medical consultations, quality of life (SF-36, SGRQ), anxiety/depression (HADS) and Medical Research Council and Baseline and Transition Dyspnea Index scores. Results: Compared to baseline, there were significant (p < 0.05) improvements in 6MWD, Wmax and muscle strength immediately after rehabilitation, and these were maintained over 12 months (p < 0.05). Effects were less pronounced in asbestosis. Overall, a significant reduction in the rate of exacerbations by 35%, antibiotic therapy by 27% and use of health care services by 17% occurred within 12 months after rehabilitation. No changes were seen in the questionnaire outcomes. Conclusions: Pulmonary rehabilitation is effective even in the complex settings of occupational respiratory diseases, providing sustained improvement of functional capacity and reducing health care utilization. Copyright (C) 2012 S. Karger AG, Basel

The European Respiratory Journal (ERJ) presents the tenth in its series of podcasts. In this instalment, Professor Enrico Clini discusses novelties in pulmonary rehabilitation, with particular focus the current review series on that topic in the ERJ.

Transcript -- How COPD can be managed. Helping patients cope with the illness and improve their quality of life

How COPD can be managed. Helping patients cope with the illness and improve their quality of life

Transcript -- How COPD can be managed. Helping patients cope with the illness and improve their quality of life

How COPD can be managed. Helping patients cope with the illness and improve their quality of life